Literature DB >> 9576069

Contrasting effects of inflammatory cytokines and glucocorticoids on the production of activin A in human marrow stromal cells and their implications.

L E Shao1, N L Frigon, A Yu, J Palyash, J Yu.   

Abstract

Human marrow stromal cells were analysed with immunocytochemical staining, Northern blot, and functional bioassay for production of activin A. Although Northern blot and immunocytochemical staining did not detect the alpha subunit of inhibin in human marrow stromal cells, RT-PCR analyses confirmed its presence, along with the expected activin beta A PCR products. Present studies showed that human marrow fibroblastoid cells were reactive with anti-activin A antibodies and that the production of beta A RNA was upregulated by pro-inflammatory cytokines/regulators like interleukin 1 alpha (IL-1 alpha), tumour necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS) or 12-O-tetradecanoylphorbol 13-acetate (TPA). IL-1 alpha or TNF-alpha stimulated-marrow stromal cells accumulated beta A RNA after 2 h of incubation, reaching a peak stimulation at approximately 8 h. Biologically active activin A molecules were detected in the conditioned media by a bioassay, and their activity was specifically inhibited by a blocking antibody or an activin-binding protein, follistatin. Accumulation of bioactive activin A in conditioned medium of human marrow stromal cells increased after incubation with IL-1 alpha or TNF-alpha. Nuclear run-off assays with TNF-alpha stimulated marrow stromal cells showed that the enhanced expression of activin A was related to an increase in its rate of transcription. In contrast to the stimulatory effect of pro-inflammatory cytokines, hydrocortisone and dexamethasone at 1 x 10(-7) to 1 x 10(-6) M inhibited both the constitutive and the cytokine-stimulated expression of activin beta A RNA, and also the production of bioactive activin A protein. The upregulation of activin A production by cytokines and its suppression by glucocorticoids imply that activin A may also act as a moderator in diverse functions including host defences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576069     DOI: 10.1006/cyto.1997.0282

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Ahamed A Khalyfa; David Gozal
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

2.  Neuroendocrine control of FSH secretion: IV. Hypothalamic control of pituitary FSH-regulatory proteins and their relationship to changes in FSH synthesis and secretion.

Authors:  Tejinder P Sharma; Terry M Nett; Fred J Karsch; David J Phillips; James S Lee; Carol Herkimer; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2012-06-07       Impact factor: 4.285

3.  Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies.

Authors:  E W Yu; K E Dolter; L E Shao; J Yu
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease.

Authors:  Sonia Vallet; Siddhartha Mukherjee; Nileshwari Vaghela; Teru Hideshima; Mariateresa Fulciniti; Samantha Pozzi; Loredana Santo; Diana Cirstea; Kishan Patel; Aliyah R Sohani; Alex Guimaraes; Wanling Xie; Dharminder Chauhan; Jesse A Schoonmaker; Eyal Attar; Michael Churchill; Edie Weller; Nikhil Munshi; Jasbir S Seehra; Ralph Weissleder; Kenneth C Anderson; David T Scadden; Noopur Raje
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 5.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

6.  The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts.

Authors:  Magnus Diller; Klaus Frommer; Berno Dankbar; Ingo Tarner; Marie-Lisa Hülser; Lali Tsiklauri; Rebecca Hasseli; Michael Sauerbier; Thomas Pap; Stefan Rehart; Ulf Müller-Ladner; Elena Neumann
Journal:  Arthritis Res Ther       Date:  2019-06-10       Impact factor: 5.156

Review 7.  The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.

Authors:  Michał Ciebiera; Marta Włodarczyk; Magdalena Zgliczyńska; Krzysztof Łukaszuk; Błażej Męczekalski; Christopher Kobierzycki; Tomasz Łoziński; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

8.  Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection.

Authors:  Rita Linko; Mark P Hedger; Ville Pettilä; Esko Ruokonen; Tero Ala-Kokko; Helen Ludlow; David M de Kretser
Journal:  BMC Infect Dis       Date:  2014-05-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.